<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Catalyst Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Catalyst Pharmaceuticals, Inc.

    Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), MuSK antibody positive myasthenia gravis (MuSK-MG), congenital myasthenic syndromes (CMS), and spinal muscular atrophy (SMA) Type 3. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Patrick J. McEnany
    • FOUNDED
      2002
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Catabasis Pharmaceuticals, Inc.

    Catabasis Pharmaceuticals, Inc.

    At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing thera...

    At Catabasis Pharmaceuticals, our mission is to...

    Filing Type:    PU
    Neopenda, PBC

    Neopenda, PBC

    Neopenda is a medical device startup creating solutions that give patients in low-...

    Neopenda is a medical device startup creating s...

    Amount Raised:    $288,184.00
    Fundraising Status:    EC
    Filing Type:    CF
    MediciNova, Inc.

    MediciNova, Inc.

    MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiri...

    MediciNova, Inc. is a publicly-traded biopharma...

    Filing Type:    PU
    Cumberland Pharmaceuticals Inc.

    Cumberland Pharmaceuticals Inc.

    We are a profitable and growing company focused on the acquisition, development an...

    We are a profitable and growing company focused...

    Filing Type:    PU
    Forward Pharma A/S

    Forward Pharma A/S

    Forward Pharma A/S is a Danish biopharmaceutical company that commenced developmen...

    Forward Pharma A/S is a Danish biopharmaceutica...

    Filing Type:    PU
    Allena Pharmaceuticals, Inc.

    Allena Pharmaceuticals, Inc.

    Allena’s lead product candidate, reloxaliase, is a first-in-class, oral enzyme t...

    Allena’s lead product candidate, reloxaliase,...

    Filing Type:    PU
    Trevi Therapeutics, Inc.

    Trevi Therapeutics, Inc.

    We are developing nalbuphine ER to treat serious neurologically mediated condition...

    We are developing nalbuphine ER to treat seriou...

    Filing Type:    PU
    Helius Medical Technologies, Inc.

    Helius Medical Technologies, Inc.

    Helius Medical Technologies, Inc. (Helius) is a neurotech company in the medical d...

    Helius Medical Technologies, Inc. (Helius) is a...

    Filing Type:    PU
    BioXcel Therapeutics, Inc.

    BioXcel Therapeutics, Inc.

    BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused o...

    BioXcel Therapeutics, Inc. is a clinical stage ...

    Filing Type:    PU
    Scholar Rock Holding Corporation

    Scholar Rock Holding Corporation

    Scholar Rock is a biopharmaceutical company focused on the discovery and developme...

    Scholar Rock is a biopharmaceutical company foc...

    Filing Type:    PU
    Sarepta Therapeutics, Inc.

    Sarepta Therapeutics, Inc.

    Sarepta Therapeutics is a U.S. commercial-stage biopharmaceutical company focused ...

    Sarepta Therapeutics is a U.S. commercial-stage...

    Filing Type:    PU
    Audentes Therapeutics, Inc.

    Audentes Therapeutics, Inc.

    Audentes Therapeutics is a leading AAV-based genetic medicines company focused on ...

    Audentes Therapeutics is a leading AAV-based ge...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.